CVE-2026-30269
Privilege escalation: self-update grants higher-role
Is CVE-2026-30269 being exploited?
Not confirmed. CVE-2026-30269 does not appear in CISA's Known Exploited Vulnerabilities catalog, which records only exploitation that has been observed and reported publicly. That is evidence of absence of a report, not evidence the flaw is unattacked. EPSS currently estimates a 0.28% probability of exploitation in the next 30 days.
How severe is CVE-2026-30269?
CVE-2026-30269 is rated Critical with a CVSS score of 9.9. Severity describes how bad exploitation would be, not how likely it is: pair it with exploitation evidence before deciding what to patch first.
Is there a patch for CVE-2026-30269?
Not known from our data. No patch reference has been recorded for CVE-2026-30269, which is not the same as no patch existing — a fix may have shipped without a tagged reference, or after this record was written. The vendor advisory is the only authority on whether a fix exists, and mitigations may be available regardless.
What does CVE-2026-30269 affect?
CVE-2026-30269 affects Doorman v0.1.0, Doorman v1.0.2. Confirm the exact affected versions against the vendor advisory before deciding you are exposed.
What should I do about CVE-2026-30269?
Apply vendor patch when available
Exploitation status reflects CISA's KEV catalog as we last synced it. Check the catalog directly.
Authenticated user can elevate own role to high-privilege account via /platform/user/{username} without permission check.
Patch when possible